329 related articles for article (PubMed ID: 29888503)
21. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.
Lisi L; Ciotti GM; Braun D; Kalinin S; Currò D; Dello Russo C; Coli A; Mangiola A; Anile C; Feinstein DL; Navarra P
Neurosci Lett; 2017 Apr; 645():106-112. PubMed ID: 28259657
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.
Fujihara T; Mizobuchi Y; Nakajima K; Kageji T; Matsuzaki K; Kitazato KT; Otsuka R; Hara K; Mure H; Okazaki T; Kuwayama K; Nagahiro S; Takagi Y
J Neurooncol; 2018 Sep; 139(2):323-332. PubMed ID: 29779087
[TBL] [Abstract][Full Text] [Related]
23. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
[TBL] [Abstract][Full Text] [Related]
24. The role of TP53 gain-of-function mutation in multifocal glioblastoma.
Olafson LR; Gunawardena M; Nixdorf S; McDonald KL; Rapkins RW
J Neurooncol; 2020 Mar; 147(1):37-47. PubMed ID: 32002804
[TBL] [Abstract][Full Text] [Related]
25. Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells.
Arsic N; Slatter T; Gadea G; Villain E; Fournet A; Kazantseva M; Allemand F; Sibille N; Seveno M; de Rossi S; Mehta S; Urbach S; Bourdon JC; Bernado P; Kajava AV; Braithwaite A; Roux P
Nat Commun; 2021 Sep; 12(1):5463. PubMed ID: 34526502
[TBL] [Abstract][Full Text] [Related]
26. [Development of barcode and proteome profiling of glioblastoma].
Naryzhnyĭ SN; Ronzhina NL; Maĭnskova MA; Beliakova NV; Pantina RA; Filatov MV
Biomed Khim; 2014; 60(3):308-21. PubMed ID: 25019393
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
28. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
Huang S; Qi P; Zhang T; Li F; He X
Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
[TBL] [Abstract][Full Text] [Related]
29. Defective p53 antiangiogenic signaling in glioblastoma.
Berger B; Capper D; Lemke D; Pfenning PN; Platten M; Weller M; von Deimling A; Wick W; Weiler M
Neuro Oncol; 2010 Sep; 12(9):894-907. PubMed ID: 20504876
[TBL] [Abstract][Full Text] [Related]
30. HIF1α and p53 Regulated MED30, a Mediator Complex Subunit, is Involved in Regulation of Glioblastoma Pathogenesis and Temozolomide Resistance.
Shukla A; Srivastava S; Darokar J; Kulshreshtha R
Cell Mol Neurobiol; 2021 Oct; 41(7):1521-1535. PubMed ID: 32705436
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.
Wang K; Wang YY; Ma J; Wang JF; Li SW; Jiang T; Dai JP
Asian Pac J Cancer Prev; 2014; 15(24):10893-8. PubMed ID: 25605197
[TBL] [Abstract][Full Text] [Related]
32. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
[TBL] [Abstract][Full Text] [Related]
33. Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis.
Wiles AK; Mehta S; Millier M; Woolley AG; Li K; Parker K; Kazantseva M; Wilson M; Young K; Bowie S; Ray S; Slatter TL; Stamp LK; Hessian PA; Braithwaite AW
Arthritis Res Ther; 2023 Apr; 25(1):62. PubMed ID: 37060003
[TBL] [Abstract][Full Text] [Related]
34. Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide.
Messaoudi K; Clavreul A; Lagarce F
Drug Discov Today; 2015 Jul; 20(7):899-905. PubMed ID: 25744176
[TBL] [Abstract][Full Text] [Related]
35. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract][Full Text] [Related]
36. BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53.
Nie E; Jin X; Wu W; Yu T; Zhou X; Zhi T; Shi Z; Zhang J; Liu N; You Y
Sci Rep; 2016 Dec; 6():39743. PubMed ID: 28000777
[TBL] [Abstract][Full Text] [Related]
37. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
38. EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.
Kapoor GS; Christie A; O'Rourke DM
Cancer Biol Ther; 2007 Apr; 6(4):571-9. PubMed ID: 17457042
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
[TBL] [Abstract][Full Text] [Related]
40. EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma.
An Z; Knobbe-Thomsen CB; Wan X; Fan QW; Reifenberger G; Weiss WA
Cancer Res; 2018 Dec; 78(24):6785-6794. PubMed ID: 30401716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
